世界のエピジェネティクス診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epigenetics Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4197 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、エピジェネティクス診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（試薬、キット、器具、酵素、サービス）、用途別市場規模（腫瘍学、非腫瘍学）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エピジェネティクス診断の市場動向 ・企業の競争状況、市場シェア ・エピジェネティクス診断の種類別市場規模と予測2016-2027（試薬、キット、器具、酵素、サービス） ・エピジェネティクス診断の用途別市場規模と予測2016-2027（腫瘍学、非腫瘍学） ・エピジェネティクス診断の北米市場規模2016-2027（アメリカ、カナダ） ・エピジェネティクス診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エピジェネティクス診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エピジェネティクス診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・エピジェネティクス診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Thermo Fisher Scientific, Inc.、Eisai Co. Ltd.、Novartis AG、Illumina, Inc.、Merck、Qiagen、Abcam plc、Diagenode Diagnostics、Active Motif、Zymo Research Corporation、CellCentric、Valirx） ・結論

The relative specificity of many epigenetic changes for neoplastic cells has allowed the identification of diagnostic, prognostic and predictive biomarkers for a number of solid tumors and hematological malignancies.
Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.

Market Analysis and Insights: Global Epigenetics Diagnostic Market
The global Epigenetics Diagnostic market size is projected to reach US$ 14450 million by 2027, from US$ 5197.9 million in 2020, at a CAGR of 15.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epigenetics Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epigenetics Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epigenetics Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epigenetics Diagnostic market.

Global Epigenetics Diagnostic Scope and Market Size
Epigenetics Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetics Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents
Kits
Instruments
Enzymes
Services

Segment by Application
Oncolog
Non-oncology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Diagnostics
Thermo Fisher Scientific, Inc.
Eisai Co. Ltd.
Novartis AG
Illumina, Inc.
Merck
Qiagen
Abcam plc
Diagenode Diagnostics
Active Motif
Zymo Research Corporation
CellCentric
Valirx

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents
1.2.3 Kits
1.2.4 Instruments
1.2.5 Enzymes
1.2.6 Services
1.3 Market by Application
1.3.1 Global Epigenetics Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncolog
1.3.3 Non-oncology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epigenetics Diagnostic Market Perspective (2016-2027)
2.2 Epigenetics Diagnostic Growth Trends by Regions
2.2.1 Epigenetics Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epigenetics Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Epigenetics Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Epigenetics Diagnostic Industry Dynamic
2.3.1 Epigenetics Diagnostic Market Trends
2.3.2 Epigenetics Diagnostic Market Drivers
2.3.3 Epigenetics Diagnostic Market Challenges
2.3.4 Epigenetics Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Diagnostic Players by Revenue
3.1.1 Global Top Epigenetics Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Epigenetics Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Epigenetics Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Diagnostic Revenue
3.4 Global Epigenetics Diagnostic Market Concentration Ratio
3.4.1 Global Epigenetics Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Diagnostic Revenue in 2020
3.5 Epigenetics Diagnostic Key Players Head office and Area Served
3.6 Key Players Epigenetics Diagnostic Product Solution and Service
3.7 Date of Enter into Epigenetics Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epigenetics Diagnostic Breakdown Data by Type
4.1 Global Epigenetics Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Epigenetics Diagnostic Forecasted Market Size by Type (2022-2027)

5 Epigenetics Diagnostic Breakdown Data by Application
5.1 Global Epigenetics Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Epigenetics Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epigenetics Diagnostic Market Size (2016-2027)
6.2 North America Epigenetics Diagnostic Market Size by Type
6.2.1 North America Epigenetics Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Epigenetics Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Epigenetics Diagnostic Market Size by Type (2016-2027)
6.3 North America Epigenetics Diagnostic Market Size by Application
6.3.1 North America Epigenetics Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Epigenetics Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Epigenetics Diagnostic Market Size by Application (2016-2027)
6.4 North America Epigenetics Diagnostic Market Size by Country
6.4.1 North America Epigenetics Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Epigenetics Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Epigenetics Diagnostic Market Size (2016-2027)
7.2 Europe Epigenetics Diagnostic Market Size by Type
7.2.1 Europe Epigenetics Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Epigenetics Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Epigenetics Diagnostic Market Size by Type (2016-2027)
7.3 Europe Epigenetics Diagnostic Market Size by Application
7.3.1 Europe Epigenetics Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Epigenetics Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Epigenetics Diagnostic Market Size by Application (2016-2027)
7.4 Europe Epigenetics Diagnostic Market Size by Country
7.4.1 Europe Epigenetics Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Epigenetics Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Epigenetics Diagnostic Market Size by Type
8.2.1 Asia-Pacific Epigenetics Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epigenetics Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epigenetics Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Epigenetics Diagnostic Market Size by Application
8.3.1 Asia-Pacific Epigenetics Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epigenetics Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epigenetics Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Epigenetics Diagnostic Market Size by Region
8.4.1 Asia-Pacific Epigenetics Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epigenetics Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epigenetics Diagnostic Market Size (2016-2027)
9.2 Latin America Epigenetics Diagnostic Market Size by Type
9.2.1 Latin America Epigenetics Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Epigenetics Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Epigenetics Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Epigenetics Diagnostic Market Size by Application
9.3.1 Latin America Epigenetics Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Epigenetics Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Epigenetics Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Epigenetics Diagnostic Market Size by Country
9.4.1 Latin America Epigenetics Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Epigenetics Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Epigenetics Diagnostic Market Size by Type
10.2.1 Middle East & Africa Epigenetics Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epigenetics Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epigenetics Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Epigenetics Diagnostic Market Size by Application
10.3.1 Middle East & Africa Epigenetics Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epigenetics Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epigenetics Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Epigenetics Diagnostic Market Size by Country
10.4.1 Middle East & Africa Epigenetics Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epigenetics Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Epigenetics Diagnostic Introduction
11.1.4 Roche Diagnostics Revenue in Epigenetics Diagnostic Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Details
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Epigenetics Diagnostic Business (2016-2021)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Eisai Co. Ltd.
11.3.1 Eisai Co. Ltd. Company Details
11.3.2 Eisai Co. Ltd. Business Overview
11.3.3 Eisai Co. Ltd. Epigenetics Diagnostic Introduction
11.3.4 Eisai Co. Ltd. Revenue in Epigenetics Diagnostic Business (2016-2021)
11.3.5 Eisai Co. Ltd. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Epigenetics Diagnostic Introduction
11.4.4 Novartis AG Revenue in Epigenetics Diagnostic Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Details
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. Epigenetics Diagnostic Introduction
11.5.4 Illumina, Inc. Revenue in Epigenetics Diagnostic Business (2016-2021)
11.5.5 Illumina, Inc. Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Epigenetics Diagnostic Introduction
11.6.4 Merck Revenue in Epigenetics Diagnostic Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Epigenetics Diagnostic Introduction
11.7.4 Qiagen Revenue in Epigenetics Diagnostic Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Abcam plc
11.8.1 Abcam plc Company Details
11.8.2 Abcam plc Business Overview
11.8.3 Abcam plc Epigenetics Diagnostic Introduction
11.8.4 Abcam plc Revenue in Epigenetics Diagnostic Business (2016-2021)
11.8.5 Abcam plc Recent Development
11.9 Diagenode Diagnostics
11.9.1 Diagenode Diagnostics Company Details
11.9.2 Diagenode Diagnostics Business Overview
11.9.3 Diagenode Diagnostics Epigenetics Diagnostic Introduction
11.9.4 Diagenode Diagnostics Revenue in Epigenetics Diagnostic Business (2016-2021)
11.9.5 Diagenode Diagnostics Recent Development
11.10 Active Motif
11.10.1 Active Motif Company Details
11.10.2 Active Motif Business Overview
11.10.3 Active Motif Epigenetics Diagnostic Introduction
11.10.4 Active Motif Revenue in Epigenetics Diagnostic Business (2016-2021)
11.10.5 Active Motif Recent Development
11.11 Zymo Research Corporation
11.11.1 Zymo Research Corporation Company Details
11.11.2 Zymo Research Corporation Business Overview
11.11.3 Zymo Research Corporation Epigenetics Diagnostic Introduction
11.11.4 Zymo Research Corporation Revenue in Epigenetics Diagnostic Business (2016-2021)
11.11.5 Zymo Research Corporation Recent Development
11.12 CellCentric
11.12.1 CellCentric Company Details
11.12.2 CellCentric Business Overview
11.12.3 CellCentric Epigenetics Diagnostic Introduction
11.12.4 CellCentric Revenue in Epigenetics Diagnostic Business (2016-2021)
11.12.5 CellCentric Recent Development
11.13 Valirx
11.13.1 Valirx Company Details
11.13.2 Valirx Business Overview
11.13.3 Valirx Epigenetics Diagnostic Introduction
11.13.4 Valirx Revenue in Epigenetics Diagnostic Business (2016-2021)
11.13.5 Valirx Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epigenetics Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reagents
Table 3. Key Players of Kits
Table 4. Key Players of Instruments
Table 5. Key Players of Enzymes
Table 6. Key Players of Services
Table 7. Global Epigenetics Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Epigenetics Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Epigenetics Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Epigenetics Diagnostic Market Share by Regions (2016-2021)
Table 11. Global Epigenetics Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Epigenetics Diagnostic Market Share by Regions (2022-2027)
Table 13. Epigenetics Diagnostic Market Trends
Table 14. Epigenetics Diagnostic Market Drivers
Table 15. Epigenetics Diagnostic Market Challenges
Table 16. Epigenetics Diagnostic Market Restraints
Table 17. Global Epigenetics Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Epigenetics Diagnostic Market Share by Players (2016-2021)
Table 19. Global Top Epigenetics Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Diagnostic as of 2020)
Table 20. Ranking of Global Top Epigenetics Diagnostic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Epigenetics Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Epigenetics Diagnostic Product Solution and Service
Table 24. Date of Enter into Epigenetics Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Epigenetics Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Epigenetics Diagnostic Revenue Market Share by Type (2016-2021)
Table 28. Global Epigenetics Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Epigenetics Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Epigenetics Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Epigenetics Diagnostic Revenue Market Share by Application (2016-2021)
Table 32. Global Epigenetics Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Epigenetics Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Epigenetics Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Epigenetics Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Epigenetics Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Epigenetics Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Epigenetics Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Epigenetics Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Epigenetics Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Epigenetics Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Epigenetics Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Epigenetics Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Epigenetics Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Epigenetics Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Epigenetics Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Epigenetics Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epigenetics Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Epigenetics Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Epigenetics Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Epigenetics Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Epigenetics Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Epigenetics Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Epigenetics Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Epigenetics Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Epigenetics Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Epigenetics Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Epigenetics Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Epigenetics Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epigenetics Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Epigenetics Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Epigenetics Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Epigenetics Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Diagnostics Company Details
Table 65. Roche Diagnostics Business Overview
Table 66. Roche Diagnostics Epigenetics Diagnostic Product
Table 67. Roche Diagnostics Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 68. Roche Diagnostics Recent Development
Table 69. Thermo Fisher Scientific, Inc. Company Details
Table 70. Thermo Fisher Scientific, Inc. Business Overview
Table 71. Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Product
Table 72. Thermo Fisher Scientific, Inc. Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 73. Thermo Fisher Scientific, Inc. Recent Development
Table 74. Eisai Co. Ltd. Company Details
Table 75. Eisai Co. Ltd. Business Overview
Table 76. Eisai Co. Ltd. Epigenetics Diagnostic Product
Table 77. Eisai Co. Ltd. Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 78. Eisai Co. Ltd. Recent Development
Table 79. Novartis AG Company Details
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Epigenetics Diagnostic Product
Table 82. Novartis AG Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 83. Novartis AG Recent Development
Table 84. Illumina, Inc. Company Details
Table 85. Illumina, Inc. Business Overview
Table 86. Illumina, Inc. Epigenetics Diagnostic Product
Table 87. Illumina, Inc. Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 88. Illumina, Inc. Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Epigenetics Diagnostic Product
Table 92. Merck Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 93. Merck Recent Development
Table 94. Qiagen Company Details
Table 95. Qiagen Business Overview
Table 96. Qiagen Epigenetics Diagnostic Product
Table 97. Qiagen Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 98. Qiagen Recent Development
Table 99. Abcam plc Company Details
Table 100. Abcam plc Business Overview
Table 101. Abcam plc Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 102. Abcam plc Recent Development
Table 103. Diagenode Diagnostics Company Details
Table 104. Diagenode Diagnostics Business Overview
Table 105. Diagenode Diagnostics Epigenetics Diagnostic Product
Table 106. Diagenode Diagnostics Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 107. Diagenode Diagnostics Recent Development
Table 108. Active Motif Company Details
Table 109. Active Motif Business Overview
Table 110. Active Motif Epigenetics Diagnostic Product
Table 111. Active Motif Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 112. Active Motif Recent Development
Table 113. Zymo Research Corporation Company Details
Table 114. Zymo Research Corporation Business Overview
Table 115. Zymo Research Corporation Epigenetics Diagnostic Product
Table 116. Zymo Research Corporation Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 117. Zymo Research Corporation Recent Development
Table 118. CellCentric Company Details
Table 119. CellCentric Business Overview
Table 120. CellCentric Epigenetics Diagnostic Product
Table 121. CellCentric Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 122. CellCentric Recent Development
Table 123. Valirx Company Details
Table 124. Valirx Business Overview
Table 125. Valirx Epigenetics Diagnostic Product
Table 126. Valirx Revenue in Epigenetics Diagnostic Business (2016-2021) & (US$ Million)
Table 127. Valirx Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Reagents Features
Figure 3. Kits Features
Figure 4. Instruments Features
Figure 5. Enzymes Features
Figure 6. Services Features
Figure 7. Global Epigenetics Diagnostic Market Share by Application: 2020 VS 2027
Figure 8. Oncolog Case Studies
Figure 9. Non-oncology Case Studies
Figure 10. Epigenetics Diagnostic Report Years Considered
Figure 11. Global Epigenetics Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Epigenetics Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Epigenetics Diagnostic Market Share by Regions: 2020 VS 2027
Figure 14. Global Epigenetics Diagnostic Market Share by Regions (2022-2027)
Figure 15. Global Epigenetics Diagnostic Market Share by Players in 2020
Figure 16. Global Top Epigenetics Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Diagnostic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Epigenetics Diagnostic Revenue in 2020
Figure 18. Global Epigenetics Diagnostic Revenue Market Share by Type (2016-2021)
Figure 19. Global Epigenetics Diagnostic Revenue Market Share by Type (2022-2027)
Figure 20. North America Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Epigenetics Diagnostic Market Share by Type (2016-2027)
Figure 22. North America Epigenetics Diagnostic Market Share by Application (2016-2027)
Figure 23. North America Epigenetics Diagnostic Market Share by Country (2016-2027)
Figure 24. United States Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Epigenetics Diagnostic Market Share by Type (2016-2027)
Figure 28. Europe Epigenetics Diagnostic Market Share by Application (2016-2027)
Figure 29. Europe Epigenetics Diagnostic Market Share by Country (2016-2027)
Figure 30. Germany Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Epigenetics Diagnostic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Epigenetics Diagnostic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Epigenetics Diagnostic Market Share by Region (2016-2027)
Figure 40. China Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Epigenetics Diagnostic Market Share by Type (2016-2027)
Figure 48. Latin America Epigenetics Diagnostic Market Share by Application (2016-2027)
Figure 49. Latin America Epigenetics Diagnostic Market Share by Country (2016-2027)
Figure 50. Mexico Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Epigenetics Diagnostic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Epigenetics Diagnostic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Epigenetics Diagnostic Market Share by Country (2016-2027)
Figure 56. Turkey Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Epigenetics Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Diagnostics Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 60. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 61. Eisai Co. Ltd. Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 63. Illumina, Inc. Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 65. Qiagen Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 66. Abcam plc Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 67. Diagenode Diagnostics Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 68. Active Motif Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 69. Zymo Research Corporation Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 70. CellCentric Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 71. Valirx Revenue Growth Rate in Epigenetics Diagnostic Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---